The 2022 HCM Academy programme was a great success, offering education on diagnosis and best practice care for patients with hypertrophic cardiomyopathy (HCM). Launched in November 2021 by PCM Scientific, the HCM Academy offers free education to healthcare providers, including live digital CME workshops and online CME and non-CME activities.
Marketing of the 2022 HCM Academy programme ran until December 2022 and focused on targeting GPs, family physicians, nurses, and community cardiology teams across the United States. It provided learners with access to education from leading HCM experts through live digital workshops, CME online modules and case studies, and patient videos that shared their real-life HCM journeys. The HCM Academy generated 126,600+ website page views, 300+ workshop attendees, and 510+ participants in educational activity.
“The HCM Academy offers the full gamut of disease. Whether it’s age, symptoms or treatment or missed opportunities. I would encourage everyone to take advantage of this unique offering” – Physician, TN
After a successful pilot phase of the HCM Academy, the programme is being expanded in 2023. Launching in February 2023, the programme will now target both primary and secondary care healthcare professionals, including GPs, primary care nurses, cardiologists, interventional cardiologists, electrophysiologists, echocardiographers, and hospital pharmacists across the United States, Canada, and Europe.
The offering will aim to further increase education and knowledge surrounding HCM and will include three primary care focused webinars, six secondary care focused webinars, and six secondary care case studies, linked to each of the webinars.